Should chemotherapy response be evaluated separately in sequential chemotherapy-radiotherapy schedules in locally advanced nonsmall-cell lung carcinoma?

Antibiot Chemother (1971). 1988:41:138-41. doi: 10.1159/000416194.

Authors

F Thomas¹, T Le Chevalier, R Arriagada, P Ruffié, P Baldeyrou

Affiliation

¹ Institut Gustave-Roussy, Villejuif, France.

PMID: 2854433
DOI: 10.1159/000416194

No abstract available

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma, Non-Small-Cell Lung / drug therapy*
Carcinoma, Non-Small-Cell Lung / pathology
Carcinoma, Non-Small-Cell Lung / radiotherapy
Cisplatin / administration & dosage
Combined Modality Therapy
Cyclophosphamide / administration & dosage
Drug Evaluation
Humans
Lomustine / administration & dosage
Lung Neoplasms / drug therapy*
Lung Neoplasms / pathology
Lung Neoplasms / radiotherapy
Male
Middle Aged
Neoplasm Recurrence, Local
Time Factors
Vindesine / administration & dosage

Substances

Lomustine
Cyclophosphamide
Cisplatin
Vindesine